BioWest Therapeutics Announces Appointment of Chief Financial Officer

About this update from Cullinan Metals Corp

[{"type":"text","content":"\nBioWest Therapeutics Announces Appointment of Chief Financial Officer\n\n\n Feb. 2, 2011 (Filing Services Canada) -- BioWest Therapeutics Inc.  (BWE - TSX) (\"BioWest\" or the \"Company\"), is pleased to announce that Ann Fehr has been appointed as chief financial officer of the Company.  Ms. Fehr is a Certified General Accountant with over 14 years of experience as a senior manager.  Ms. Fehr is well versed in the corporate governance and regulatory financial reporting for publicly traded companies.  She currently serves as chief financial officer for Global Minerals Ltd., New High Ridge Resources and Global Uranium.Jeff Charpentier has resigned from his position as chief financial officer of the Company to pursue other career opportunities.  The board of directors thanks Mr. Charpentier for his contributions to BioWest and wishes him all the best in the future.  Contact: Bruce SchmidtTel: (604) 221-9666 About BioWestBioWest is committed to advancing therapy, improving health, and enriching life by developing and commercializing drugs for the treatment of unmeet medical needs for various diseases. The Company's programs include drug candidates for: the prevention of catheter related infections, for the treatment of hospital-acquired infections, the treatment of dermatological diseases, and the treatment of hepatitis B infections. BioWest is headquartered in Vancouver, British Columbia, Canada.Source: BioWest Therapeutics Inc. (TSX - BWE) http://www.migenix.comMaximum News Dissemination by Filing Services Canada Inc. *www.usetdas.com\n\n\n\n","length":1814,"tagName":"div"}]

More updates from Cullinan Metals Corp